CTA
IONS icon

Carillon Tower Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Carillon Tower Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-178,875
Closed -$10.8M – 461
2019
Q4 		$10.8M Buy
+178,875
New +$10.7M 0.07% 321
2019
Q3 		– Sell
-55,500
Closed -$3.57M – 482
2019
Q2 		$3.57M Sell
55,500
-147,825
-73% -$10.4M 0.02% 416
2019
Q1 		$16.5M Sell
203,325
-52,325
-20% -$3.38M 0.12% 268
2018
Q4 		$13.8M Buy
255,650
+6,050
+2% +$309K 0.12% 260
2018
Q3 		$12.9M Buy
249,600
+13,125
+6% +$617K 0.09% 303
2018
Q2 		$9.85M Buy
236,475
+34,175
+17% +$1.51M 0.08% 325
2018
Q1 		$8.92M Buy
+202,300
New +$10.3M 0.07% 320

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Carillon Tower Advisers's IONS Position: Q1 2020 in Review

Carillon Tower Advisers sold out of Ionis Pharmaceuticals (IONS) in Q1 2020, closing a stake of 178,875 shares — an estimated $10.8M sold.

Carillon Tower Advisers first reported a position in IONS in Q1 2018 and held it in 7 quarters. The position peaked at $16.5M in Q1 2019. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

  • Carillon Tower Advisers reported no remaining Ionis Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 178,875 Ionis Pharmaceuticals shares in Q1 2020, an estimated $10.8M.
  • Carillon Tower Advisers first reported a position in Ionis Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Carillon Tower Advisers's Ionis Pharmaceuticals position peaked at $16.5M in Q1 2019.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on Carillon Tower Advisers's 13F filing for Q1 2020, filed 11 May 2020.